MULTI BARRIER REVERSE CONVERTIBLE - ROCHE GS/LONZA GROUP/NOVARTIS N Share Price

Certificat

KQKRCH

CH1182623889

Market Closed - Bid/Ask 08:50:01 14/05/2024 pm IST After market 08:45:00 pm
100.4 CHF -0.07% Intraday chart for MULTI BARRIER REVERSE CONVERTIBLE - ROCHE GS/LONZA GROUP/NOVARTIS N 100.4 +0.05%
Current month-0.21%
3 months+3.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
14/24/14 100.4 -0.07%
13/24/13 100.4 -0.01%
10/24/10 100.4 -0.61%
08/24/08 101 +0.08%
07/24/07 101 +0.22%

Delayed Quote Swiss Exchange

Last update May 14, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Raiffeisen Switzerland B.V.
KQKRCH
ISINCH1182623889
Date issued 05/08/2022
Strike 316.7 CHF
Maturity 05/08/2024 (82 Days)
Parity 0.32 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 101 CHF
Lowest since issue 64.62 CHF
Spread 8 CHF
Spread %0.79%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
224.6 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.39%
Consensus
  1. Stock Market
  2. Certificates
  3. KQKRCH Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW